In a large cohort study, serum annexin A2 was significantly elevated in early-stage hepatocellular carcinoma patients compared to healthy controls and patients with other malignancies such as lung or bowel cancer. This evidence concerns the gene ANXA2 and hepatocellular carcinoma.